| scholarly article | Q13442814 |
| P50 | author | Susana Ravassa | Q37369498 |
| Begoña López | Q37369520 | ||
| P2093 | author name string | Javier Díez | |
| Arantxa González | |||
| Ramón Querejeta | |||
| Mariano Larman | |||
| María A Fortuño | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | essential hypertension | Q988405 |
| P304 | page(s) | 75-80 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Hypertension | Q5958695 |
| P1476 | title | Stimulation of cardiac apoptosis in essential hypertension: potential role of angiotensin II. | |
| P478 | volume | 39 |
| Q36015485 | A synopsis of research in cardiac apoptosis and its application to congestive heart failure |
| Q80675818 | Aldosterone induces circadian gene expression of clock genes in H9c2 cardiomyoblasts |
| Q34986413 | An updated concept for left ventricular hypertrophy risk in hypertension |
| Q63915349 | Apoptosis in the cardiovascular system: incidence, regulation, and therapeutic options |
| Q44927164 | Bcl-2 is a key factor for cardiac fibroblast resistance to programmed cell death. |
| Q37595599 | Cardiovascular effects of losartan and its relevant clinical application |
| Q57793110 | Changes of Bax, Bcl-2, chemokine receptor-2, monocyte chemoattractant protein-1, and transforming growth factor β1 genes in the left ventricle of spontaneously hypertensive rat after losartan treatment |
| Q57395355 | Clinical implications of apoptosis in hypertensive heart disease |
| Q53113411 | Decreased Nox4 levels in the myocardium of patients with aortic valve stenosis. |
| Q33232137 | Effects of angiotensin II receptor antagonist, Losartan on the apoptosis, proliferation and migration of the human pancreatic stellate cells |
| Q42873628 | Evidence that apoptotic signalling in hypertrophic cardiomyocytes is determined by mitochondrial pathways involving protein kinase Cδ |
| Q33650440 | Human cardiac tissue in a microperfusion chamber simulating extracorporeal circulation--ischemia and apoptosis studies |
| Q37620005 | Increased Apoptosis in the Paraventricular Nucleus Mediated by AT1R/Ras/ERK1/2 Signaling Results in Sympathetic Hyperactivity and Renovascular Hypertension in Rats after Kidney Injury |
| Q57395357 | Involvement of cardiomyocyte survival–apoptosis balance in hypertensive cardiac remodeling |
| Q44559477 | Lack of Apaf-1 expression confers resistance to cytochrome c-driven apoptosis in cardiomyocytes |
| Q38215381 | Markers of left ventricular decompensation in aortic stenosis. |
| Q44307940 | Nicotine inhibits cardiac apoptosis induced by lipopolysaccharide in rats |
| Q64230078 | Osthole protects against Ang II-induced endotheliocyte death by targeting NF-κB pathway and Keap-1/Nrf2 pathway |
| Q35675241 | PET Imaging of the AT1 receptor with [11C]KR31173 |
| Q37799428 | Prevention, Diagnosis, and Treatment of Hypertensive Heart Disease |
| Q88723805 | Programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond |
| Q37812268 | Quantitative left ventricular contractility analysis under stress: a new practical approach in follow-up of hypertensive patients |
| Q33554981 | Recombinant adeno-associated virus-mediated human kallikrein gene therapy protects against hypertensive target organ injuries through inhibiting cell apoptosis |
| Q36067015 | Regulation of therapeutic apoptosis: a potential target in controlling hypertensive organ damage |
| Q81618561 | Relationship between arterial stiffness and myocardial damage in patients with newly diagnosed essential hypertension |
| Q37724503 | Review article: Left ventricular dysfunction and heart failure in metabolic syndrome and diabetes without overt coronary artery disease--do we need to screen our patients? |
| Q28567458 | Roles of insulin-like growth factor II in cardiomyoblast apoptosis and in hypertensive rat heart with abdominal aorta ligation |
| Q48051165 | Short-term hypoxia upregulated Mas receptor expression to repress the AT1 R signaling pathway and attenuate Ang II-induced cardiomyocyte apoptosis |
| Q35660829 | Target organ involvement in hypertension: a realistic promise of prevention and reversal |
| Q36596749 | The renin-angiotensin system: a therapeutic target in atrial fibrillation |
| Q38743657 | The role of cardiac biochemical markers in aortic stenosis. |
Search more.